Nkarta, Inc. (NKTX)

2.815 +0.02 (+0.90%) USD  |  NASDAQ  |  Sep 04, 12:20
More

Nkarta Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for NKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to 2018. Start Trial.
Date Value
December 31, 2019 --
Date Value
December 31, 2018 --

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Theriva Biologics, Inc. --
Unicycive Therapeutics, Inc. --
OnKure Therapeutics, Inc. --
ACADIA Pharmaceuticals, Inc. Upgrade